MicroRNA-128-3p inhibiting epithelial-mesenchymal transition of ovarian cancer cells by regulating zince finger E-bonx binding homeobox 1

XU Yu-hong ZHANG Hui-ya WANG Yun-gen CHEN Jun-xia

Acta Anatomica Sinica ›› 2022, Vol. 53 ›› Issue (6) : 762-768.

PDF(8405 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(8405 KB)
Acta Anatomica Sinica ›› 2022, Vol. 53 ›› Issue (6) : 762-768. DOI: 10.16098/j.issn.0529-1356.2022.06.010
Cancer Biology

MicroRNA-128-3p inhibiting epithelial-mesenchymal transition of ovarian cancer cells by regulating zince finger E-bonx binding homeobox 1

  • XU  Yu-hong  ZHANG  Hui-ya  WANG  Yun-gen  CHEN  Jun-xia*
Author information +
History +

Abstract

Objective To investigate the effect of mircoRNA-128-3p (miR-128-3p) on epithelial-mesenchymal transition (EMT) of ovarian cancer cells and its regulatory mechanism on zinc finger E-box binding homobox 1(ZEB1).   Methods Real-time PCR technology was used to detect the expression of miR-128-3p in epithelial ovarian cancer tissue (EOC) and adjacent normal tissue(30 cases each), and to observe whether there was a difference. Two human ovarian cancer cell lines, SKOV3 and A2780, were selected and transfected respectively. MiR-128-3p mimic (miR-128-3p mimic group) and negative control mimic (NC mimic group) were used to detect the expression of miR-128-3p in 4 groups by Real-time PCR to verify the interference effect. Transwell assay was used. The migration and invasion abilities of the four groups of cells were observed. The regulatory relationship between miR-128-3p and ZEB1 was verified by dual luciferase assay, and the expression level of ZEB1 protein after overexpression of miR-128-3p was detected by Western blotting; pcDNA-ZEB1 was transfected into SKOV3 and A2780 cell lines to make it overexpression of ZEB1 was divided into NC mimic group, miR-128-3p mimic group, and miR-128-3p mimic+pcDNA-ZEB1 group. Western blot  ting was used to detect the EMT-related protein E-cadherin in 6 groups of cells and the expression level of vimentin.   Results Real-time PCR result showed that the expression of miR-128-3p in EOC tissues decreased compared with that in adjacent tissues(P<0.01); The relative expression of miR-128-3p in the miR-128-3p mimic group was higher than that in the NC mimic group, while the numbers of migrating cells and invasive cells were lower than those in the NC mimic group (P<0.01). The result  of dual luciferase experiments showed that miR-128-3p had a negative regulatory effect on ZEB1. In SKOV3 and A2780 cells, the relative expression of ZEB1 protein in the miR-128-3p mimic group was lower than that in the NC mimic group, while the relative protein expression of Ecadhein was higher than that in the NC mimic group (P<0.01). The relative protein expression of E-cadhein in the miR-128-3p mimic+pcDNA-ZEB1 group was lower than that in the miR-128-3p mimic group (P<0.01). In SKOV3 and A2780 cells, the relative protein expression of vimentin in the miR-128-3p mimic group was lower than that in the NC mimic group, and the relative p  rotein expression of vimentin in the miR-128-3p mimic+pcDNA-ZEB1 group was higher than that in the miR-128-3p mimic group (P<0.01).   Conclusion The expression of miR-128-3p decreases in epithelial ovarian cancer tissues, which may be due to the regulation of ZEB1 to affect the expression of EMT-related proteins and participate in the EMT process of ovarian cancer cells.

Key words

MicroRNA-128-3P / Zincfinger E-box binding homobox 1 / Ovarian cancer / Epithelial-mesenchymal transition / Real-time PCR / Human 

Cite this article

Download Citations
XU Yu-hong ZHANG Hui-ya WANG Yun-gen CHEN Jun-xia. MicroRNA-128-3p inhibiting epithelial-mesenchymal transition of ovarian cancer cells by regulating zince finger E-bonx binding homeobox 1[J]. Acta Anatomica Sinica. 2022, 53(6): 762-768 https://doi.org/10.16098/j.issn.0529-1356.2022.06.010

References

[1]Gaona LP, Medina LA, Maga PK. Epidemiology of ovarian cancer [J]. Chin Clin Oncol, 2020,9(4): 47.
[2]Liu B, Nash J, Runowicz C, et al. Ovarian cancer immunotherapy: opportunities, progresses and challenges [J]. J Hematol Oncol, 2010,3(1):7-18.
[3]Mei Y, Zhang L, Yang H, et al. Regulatory effect of grainyhead-like 2 gene on proliferation of epithelial ovarian cancer cells by nuclear factor erythroid-2-related factor 2 transcription [J]. Acta Anatomica Sinica,2019,50(4):477-482. (in Chinese)
梅燕,张琳,杨红,等.核因子E2相关因子2转录调控粒状头样2基因影响上皮性卵巢癌细胞活力[J].解剖学报,2019,50(4):477-482.
[4]Loret N, Denys H, Tummers P, et al. The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance [J]. Cancers, 2019,11(6):838-860.
[5]Koutsaki M, Spandidos DA, Zaravinos A. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics [J]. Cancer letters, 2014,351(2): 173-181.
[6]Zhang X, Jiang ZhM, Cheng XY, et al.MicroRNA-98-5p targeting ribonucleotide reductase small subunit M2 regulating cisplatin resistance in cervical cancer cells [J]. Acta Anatomica Sinica,2021,52(3):432-438. (in Chinese)
张霞,蒋志明,程晓燕,等.微小RNA-98-5p靶向调控核糖核苷酸还原酶小亚基M2调控宫颈癌细胞顺铂的耐药性[J].解剖学报,2021,52(3):432-438.
[7]Wu H, Liu J, Zhang Y, et al. miR-22 suppresses cell viability and EMT of ovarian cancer cells via NLRP3 and inhibits PI3K/AKT signaling pathway [J]. Clin Transla Oncology, 2021,23(2): 257-264.
[8]Zhao LL, Li R, Xu SL, et al. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer[J]. Acta Biochim Biophys Sin(Shanghai), 2018, 50(2): 171-180.
[9]Bai J, Zhang X, Shi DD, et al. Exosomal miR-128-3p promotes epithelial-to-mesenchymal transition in colorectal cancer cells by targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 Signaling[J]. Front Cell Dev Biol, 2021,9:568738. 
[10] Feng W, Guo RX, Zhang DY, et al. Circ-ABCB10 knockdown inhibits the malignant progression of cervical cancer through microRNA-128-3p/ZEB1 axis[J]. Biol Proced Online, 2021,23(1): 17.
[11]Zhu L, Wang A, Gao M, Duan X, Li Z. LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-1283p/CKD14 axis[J]. Cancer Cell Int, 2020, 20:145.
[12]Wang Q, Li XP, Zhou X, et al. A single-nucleotide polymorphism in lnc-LAMC2-1:1 interferes with its interaction with miR-128 to alter the expression of deleted in colorectal cancer and its effect on the survival rate of subjects with ovarian cancer[J]. J Cell Biochem, 2020, 129(1): 227-232.
[13]Shi Y, Yan FG, Wang FP, et al. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells[J]. Tissue Cell, 2021,72:101534.
[14]Liu YY, Fu XM, Wang XY, et al. Long non-coding RNA OIP5-AS1 facilitates the progression of ovarian cancer via the miR-128-3p/CCNG1 axis.[J]. Mol Med Rep, 2021, 23(5):388-399.
[15]Elsayed AM, Amero P, Salama SA, et al. Back to the future: rethinking the great potential of lncRNA(S) for optimizing chemotherapeutic response in ovarian cancer[J]. Cancers(Basel), 2020,12(9):2406.
[16]Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1[J]. Nat Cell Biol, 2008,10(5):593-601.
[17]Frixa T, Sacconi A, Cioce M, et al. MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migration[J]. Carcinogenesis. 2018,39(2): 293-304.
PDF(8405 KB)

Accesses

Citation

Detail

Sections
Recommended

/